- Open Access
Correction to: Procalcitonin-guided antibiotic therapy in critically ill adults: a meta-analysis
BMC Infectious Diseases volume 19, Article number: 1077 (2019)
- The original article was published in BMC Infectious Diseases 2017 17:514
Correction to: BMC Infect Dis
After publication of the original article , the authors have reported that the software developers had used a new amended version of the software called “v0.9.5.10” instead of “v0.9.5.5”, which is referred to in the original article.
Thus, the authors have conducted trial sequential analysis with new version of the software for the two continuous end-points. All corrections are following:
1. “v0.9.5.5” in the Trial sequential analysis (methods section) is corrected to “v0.9.5.10”.
2. The estimated required information size of Length of hospitalization (7161, results section) is corrected to “7242”.
3. Fig. 5 is below updated.
The conclusions are as same as published in the original article.
 References: Zhang et al. BMC Infectious Diseases (2017) 17:514, DOI: 10.1186/s12879-017-2622-3
Zhang T, Wang Y, Yang Q, Dong Y. Procalcitonin-guided antibiotic therapy in critically ill adults: a meta-analysis. BMC Infect Dis. 2017;17(1):514.
About this article
Cite this article
Zhang, T., Wang, Y., Yang, Q. et al. Correction to: Procalcitonin-guided antibiotic therapy in critically ill adults: a meta-analysis. BMC Infect Dis 19, 1077 (2019). https://doi.org/10.1186/s12879-019-4707-7